Abstract
The existence of the non-hematopoietic stem/progenitor cells from bone marrow known as mesenchymal stem cells, marrow stromal cells, or multipotent mesenchymal stromal cells (MSCs), was first suggested over a hundred years ago. Definitive evidence that bone marrow contains cells that can differentiate into fibroblasts as well as other mesenchymal cells has been available since the mid-1970s. Over the last three decades, a great deal of research has been conducted on MSCs in laboratories worldwide. It has been found that these cells are easily isolated from small volumes of bone marrow, can be expanded to large numbers in a relatively short period of time with basic tissue culture techniques and can undergo differentiation into several different tissue types. In addition, it has been shown that MSCs are a part of the body’s natural repair mechanism and, thus, there has been great interest in using MSCs for treatment of various diseases and injuries, such as diabetes, chronic heart failure, Parkinson’s disease, Alzheimer’s disease, and spinal cord injury, to name just a few. Although the knowledge of these cells has grown exponentially and interest in MSCs has increased proportionally, each lab has developed their own protocols and methods of isolation, culture and characterization, thus, making it difficult to compare the results from experiments with MSCs from different labs. In spite of the ease with which these cells are isolated and cultured, there are some important criteria for the culture of these cells which must be observed in order to produce MSCs which have the capability to expand, multidifferentiate, form colonies and also to perform well when used for in vitro and in~vivo studies and in clinical therapies. This chapter will cover human MSC isolation, expansion, characterization and potential therapeutic uses.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cohnheim J. (1867) Ueber Ebtzuendung and Eiterung. Arch. Path. Anat. Physiol. Klin. Med. 40: 1–79.
Friedenstein AJ, Gorskaja U, Kulagina NN. (1976) Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp. Hematol. 4: 267–274.
Prockop DJ, Sekiya I, Colter DC. (2001) Isolation and characterization of rapidly self-renewing stem cells from cultures of human marrow stromal cells. Cytotherapy 3:393–396.
Sanchez-Ramos J, Song S, Cardozo-Pelaez F, Hazzi C, Stedeford T, Willing A, Freeman TB, Saporta S, Janssen W, Patel N, Cooper DR, Sanberg PR. (2000) Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp. Neurol. 164: 247–256.
Woodbury D, Schwarz EJ, Prockop DJ, Black IB. (2000) Adult rat and human bone marrow stromal cells differentiate into neurons. J. Neurosci. Res. 61: 364–370.
Kotton DN, Ma BY, Cardoso WV, Sanderson EA, Summer RS, Williams MC, Fine A. (2001) Bone marrow-derived cells as progenitors of lung alveolar epithelium. Development 128: 5181–5188.
Wakitani S, Saito T, Caplan AI. (1995) Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18: 1417–1426.
Fukuda K. (2002) Molecular characterization of regenerated cardiomyocytes derived from adult mesenchymal stem cells. Congenit. Anom. Kyoto 42: 1–9.
Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, Deans RJ, Krause DS, Keating A. (2005) Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 7: 393–395.
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop DJ, Horwitz E. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315–317.
Meyerrose TE, Roberts M, Ohlemiller KK, Vogler CA, Wirthlin L, Nolta JA, Sands MS. (2008) Lentiviral-transduced human mesenchymal stem cells persistently express therapeutic levels of enzyme in a xenotransplantation model of human disease. Stem Cells 26: 1713–1722.
Zhang XY, La Russa VF, Reiser J. (2004) Transduction of bone-marrow-derived mesenchymal stem cells by using lentivirus vectors pseudotyped with modified RD114 envelope glycoproteins. J. Virol. 78(3):1219–1229.
Rubio D, Garcia-Castro J, Martin MC, de la FR, Cigudosa JC, Lloyd AC, Bernad A. (2005) Spontaneous human adult stem cell transformation. Cancer Res. 65: 3035–3039.
Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, Mavilio F. (1998) Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279: 1528–1530.
Chopp M, Zhang XH, Li Y, Wang L, Chen J, Lu D, Lu M, Rosenblum M. (2000) Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation. Neuroreport 11(13): 3001–3005.
Olson L, Widenfalk J, Josephson A, Greitz D, Klason T, Kiyotani T, Lipson A, Ebendal T, Cao Y, Hofstetter C, Schwartz E, Prockop D, Manson S, Jubran M, Lindqvist E, Lundströmer K, Nosrta I, Nosrat C, Brené S, Spenger C. (2001) Experimental spinal cord injury models: protective and repair strategies. In: Tissue Engineering for Therapeutic Use 5. Y. Ikada and N. Ohshima, Eds. pp 21–36.
Zacharek A, Chen J, Cui X, Li A, Li Y, Roberts C, Feng Y, Gao Q, Chopp M. (2007) Angiopoietin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke. J. Cereb. Blood Flow Metab. 27(10): 1684–1691.
Schinköthe T, Bloch W, Schmidt A. (2008) In vitro secreting profile of human mesenchymal stem cells. Stem Cells Dev. 17(1): 199–206.
Penolazzi L, Lambertini E, Tavanti E, Torreggiani E, Vesce F, Gambari R, Piva R. (2008) Evaluation of chemokine and cytokine profiles in osteoblast progenitors from umbilical cord blood stem cells by BIO-PLEX technology. Cell Biol. Int. 32(2): 320–325.
Gerdoni E, Gallo B, Casazza S, Musio S, Bonanni I, Pedemonte E, Mantegazza R, Frassoni F, Mancardi G, Pedotti R, Uccelli A. (2007) Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann. Neurol. 61(3): 219–227.
Aggarwal S, Pittenger MF. (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105(4): 1815–1822.
Le Blanc K, Ringdén O. (2007) Immunomodulation by mesenchymal stem cells and clinical experience. J. Intern. Med. 262(5): 509–525.
Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI, Zhao RC, Shi Y. (2008) Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2(2):141–150.
Ortiz LA, Dutreil M, Fattman C, Pandey AC, Torres G, Go K, Phinney DG. (2007) Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc. Natl. Acad. Sci. USA. 104(26): 11002–11007.
Gupta N, Su X, Popov B, Lee JW, Serikov V, Matthay MA. (2007) Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J. Immunol. 179(3): 1855–1863.
Munoz JR, Stoutenger BR, Robinson AP, Spees JL, Prockop DJ. (2005) Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc. Natl. Acad. Sci. USA. 102(50):18171–18176.
Lee RH, Seo MJ, Reger RL, Spees JL, Pulin AA, Olson SD, Prockop DJ. (2006) Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc. Natl. Acad. Sci. USA. 103(46):17438–17443.
Spees JL, Olson SD, Ylostalo J, Lynch PJ, Smith J, Perry A, Peister A, Wang MY, Prockop DJ. (2003) Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma. Proc. Natl. Acad. Sci. USA. 100(5): 2397–2402.
Spees JL, Olson SD, Whitney MJ, Prockop DJ. (2006) Mitochondrial transfer between cells can rescue aerobic respiration. Proc. Natl. Acad. Sci. USA. 103(5): 1283–1288.
Prockop DJ, Gregory CA, Spees JL. (2003) One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Proc. Natl. Acad. Sci. USA. 100 Suppl 1:11917–11923.
Prockop DJ. (2007) “Stemness” does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs). Clin. Pharmacol. Ther. September;82(3): 241–243.
Caplan AI, Dennis JE. (2006) Mesenchymal stem cells as trophic mediators. J. Cell. Biochem. August 1;98(5): 1076–1084.
Wolfe M, Pochampally R, Swaney W, Reger RL. (2008) Isolation and culture of bone marrow-derived human multipotent stromal cells (hMSCs). Methods Mol. Biol. 449: 3–25.
Reger RL, Wolfe MR. (2008) Freezing harvested hMSCs and recovery of hMSCs from frozen vials for subsequent expansion, analysis, and experimentation. Methods Mol. Biol. 449:109–116.
DiGirolamo CM, Stokes D, Colter D, Phinney DG, Class R and Prockop DJ. (1999) Propagation and senescence of human marrow stromal cells in culture: a simple colony forming assay identifies samples with the greatest potential to propagate and differentiate. Br. J. Haematol. 107: 275–281.
Reger RL, Tucker AH, Wolfe MR. (2008) Differentiation and characterization of human MSCs. Methods Mol. Biol. 449: 93–107.
Baksh D, Song L, Tuan RS. (2004). Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J. Cell. Mol. Med. 8(3): 301–316.
Bruder SP, Jaiswal N, Haynesworth SE. (1997). Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J. Cell. Biochem. 64: 278–294.
Bruder SP, Kurth AA, Shea M, Hayes WC, Jaiswal N, Kadiyala S. (1998). Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J. Orthop. Res. 16: 155–162.
Prockop DJ. (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276: 71–74.
Sekiya I, Larson BL, Smith JR, Pochampally R, Cui JG, Prockop DJ. (2002) Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 20: 530–541.
Sekiya I, Larson BL, Vuoristo JT, Reger RL, Prockop DJ. (2005) Comparison of effect of BMP-2, -4, and -6 on in vitro cartilage formation of human adult stem cells from bone marrow stroma. Cell Tissue Res. 320(2): 269–276.
Smith JR, Pochampally R, Perry A, Hsu S-C, Prockop DJ. (2004). Isolation of a highly clonogenic and multipotential subfraction of adult stem cells from bone marrow stroma. Stem Cells 22: 823–831.
Sekiya I, Colter DC, Prockop DJ. (2001) BMP-6 enhances chondrogenesis in a subpopulation of human marrow stromal cells. Biochem. Biophys. Res. Commun. 284: 411–418.
Eaves C, Glimm H, Eisterer W, Audet J, Maguer-Satta V, Piret J. (2001) Characterization of human hematopoietic cells with short-lived in vivo repopulating activity. Ann. NY Acad. Sci. 938: 63–70; discussion 70–71.
Ohtaki H, Ylostalo J, Foraker JE, Robinson AP, Reger RL, Shioda S, Prockop DJ. (2008). Stem/progenitor cells from bone marrow (hMSCs) decrease neural cell death in global ischemia by modulation of the inflammatory/immune responses. Proc. Natl. Acad. Sci. USA. 105(38): 14638–14643.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Wolfe, M., Tucker, A., Reger, R.L., Prockop, D.J. (2009). Multipotent Stromal Cells (hMSCs). In: Masters, J.R., Palsson, B.Ø. (eds) Human Adult Stem Cells. Human Cell Culture, vol 7. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-2269-1_2
Download citation
DOI: https://doi.org/10.1007/978-90-481-2269-1_2
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-2268-4
Online ISBN: 978-90-481-2269-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)